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Abstract
Background: Fumaria parviflora Linn. (Fumariaceae), is a small branched annual herb found in many parts of the
world including Saudi Arabia and Pakistan. This study was designed to provide pharmacological basis for the
medicinal use of Fumaria parviflora in gut motility disorders.
Methods: The in-vivo prokinetic and laxative assays were conducted in mice. Isolated intestinal preparations (ileum
and jejunum) from different animal species (mouse, guinea-pig and rabbit) were separately suspended in tissue
baths containing Tyrode’s solution bubbled with carbogen and maintained at 37°C. The spasmogenic responses
were recorded using isotonic transducers coupled with PowerLab data acquisition system.
Results: The aqueous-methanol extract of Fumaria parviflora (Fp.Cr), which tested positive for the presence of
alkaloids, saponins, tannins and anthraquinones showed partially atropine-sensitive prokinetic and laxative activities
in the in-vivo in mice at 30 and 100 mg/kg. In the in-vitro studies, Fp.Cr (0.01-1 mg/ml) caused a concentration-
dependent atropine-sensitive stimulatory effect both in mouse tissues (jejunum and ileum), and rabbit jejunum but
had no effect in rabbit ileum. In guinea-pig tissues (ileum and jejunum), the crude extract showed a concentration-
dependent stimulatory effect with higher efficacy in ileum and the effect was partially blocked by atropine,
indicating the involvement of more than one types of gut-stimulant components (atropine-sensitive and
insensitive). This could be a plausible reason for the greater efficacy of Fp.Cr in gut preparations of guinea-pig than
in rabbit or mouse.
Conclusions: This study shows the prokinetic, laxative and spasmodic effects of the plant extract partially mediated
through cholinergic pathways with species and tissue-selectivity, and provides a sound rationale for the medicinal
use of Fumaria parviflora in gut motility disorders such as, indigestion and constipation. This study also suggests
using different species to know better picture of pharmacological profile of the test material.
Background
In traditional medicine, gut motility disorders such as,
indigestion and constipation are considered root cause
of ill health [1], where self-medication using natural pro-
d u c t si sc o m m o na m o n g s tt h ep u b l i c[ 2 ] .I ti sn o t
uncommon that constipation usually accompanies with
indigestion and different classes of chemical drugs, such
as prokinetics and laxatives are used in the conventional
medicine for these disorders [3]. On the other hand,
herbal remedies (known to contain multiple chemicals)
are considered relatively safe and useful in such disor-
ders, thus a single plant offers multiple therapeutic ben-
efits [4].
Fumaria parviflora Linn. (Fumariaceae), locally
known in Saudi Arabia as ‘Homaira’, is a small branched
annual herb found in many parts of the world including
Middle East [5] and South Asia [6]. In the Greco-Arab
(Unani) traditional medicine, the plant is widely used in
gut disorders such as, indigestion, constipation, abdom-
inal cramps and diarrhea [5,6]. However, the plant has
not been studied for its medicinal use in indigestion or
constipation except a preliminary in-vitro study showing
a cholinergic activity on the part of another species
(Fumaria indica) of this genus [7]. In this study, we
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sesses prokinetic and laxative properties in the in-vivo
models and the detailed study on the possible mode of
action was carried out using the in-vitro experiments
involving different species and tissues.
Phytochemical studies on Fumaria parviflora have
shown the presence of alkaloids, such as, adlumidiceine,
coptisine, fumariline, parfumine, protopine [8], fumara-
nine, fumaritine, paprafumicin, paprarine [9], fumaro-
phycine, cryptopine, sanactine, stylopine, bicuculline,
adlumine, perfumidine and dihydrosanguirine [10].
However to the best of our knowledge, none of the
reported compounds or the parent plant has been stu-
died for its laxative or prokinetic activity.
Methods
Plant material
The aerial parts of Fumaria parviflora were collected
from Al-Souda area in Abha, Saudi Arabia in March,
2010. The plant was authenticated by Dr. Mohammad
Yusuf, Taxonomist at the College of Pharmacy, King
Saud University and the specimen has been preserved at
the herbarium of the College of Pharmacy (voucher #
15515), King Saud University, Riyadh, Saudi Arabia, and
also at the Natural Product Research Division, Depart-
ment of Biological and Biomedical Sciences, The Aga
Khan University, Karachi with voucher # Fp-AP-23-10-
99.
Extraction procedure
By following a previously described method [11], the
aerial parts of Fumaria parviflora were soaked in the
aqueous-methanol (30:70) for 3 days and filtered
through muslin cloth and Whatman (Maidstone, UK)
No.1 filter paper simultaneously. This procedure was
repeated three times, and all the filtrates were pooled
and evaporated in rotary evaporator (model RE-111,
Buchi, Flawil, Switzerland) under reduced pressure to
finally obtain the crude extract. The yield of thick dark
brown past-like mass was 26.6% w/w.
Phytochemical screening
Phytochemical investigation of the crude extract of Fp.
Cr was carried out qualitatively for the presence of alka-
loids, saponins, tannins and anthraquinones as plant
constituents according to a standard method [12].
Chemicals
Acetylcholine perchlorate (ACh), atropine sulphate, car-
bachol (CCh), histamine hydrochloride, 5-hydroxytrypta-
mine (5-HT), pyrilamine maleate and hexamethonium
chloride were purchased from Sigma-Aldrich Chemicals
Company (St Louis, MO, USA). SB203186 (1-piperidiny-
lethyl-1H-indole-3-carbox y l a t e )w a sp u r c h a s e df r o m
Tocris (Ballwin, MO, USA). All chemicals used were of
the analytical grade available and solubilized in distilled
water.
Animals
BALB/c mice (weighing 20-25 g), guinea-pigs (weighing
400-600 g) and local breed rabbits (weighing 1-1.5 kg)
of either sex, were housed at the animal house of the
Aga Khan University under a controlled environment
(23-25°C). The animals were kept in respective standard
cages and were fasted accordingly before starting the
experiments, while in routine they had free access to
feed and water. The experiments were performed with
the rulings of the Institute of Laboratory Animal
Resources, Commission on Life Sciences, National
Research Council [13] and approved by the Ethical
Committee of the Aga Khan University.
In-vivo experiments
Charcoal meal gut transit test
Mice fasted for 12 h were divided into different groups,
each containing six animals. One group was treated
with saline (10 ml/kg), which served as a negative con-
trol and the next group was administered (CCh, 1 mg/
kg) as the positive control. The next two groups were
treated with increasing doses of Fp.Cr (30 and 100 mg/
k g ,o r a l l y ,p . o . ) ,a c t i n ga st h et e s tg r o u p s .A f t e r1 5m i n
of treatment, each animal received 0.3 ml of charcoal
meal in the form of suspension in distilled water con-
taining 10% gum acacia, 10% vegetable charcoal and
20% starch. The animals were sacrificed following 30
min of treatment, and the abdomen immediately cut
opened to excise the whole small intestine. The length
of the small intestine and the distance between the
pylorus region and the front of the charcoal meal was
measured to obtain the charcoal transport ratio or per-
centage. In order to assess the involvement of ACh-like
prokinetic effect of the extract and CCh, respectively,
further groups of mice were pretreated with atropine
(10 mg/kg, intraperitoneal, i.p.) 15 min prior the admin-
istration of the extract or CCh [14].
Laxative activity test
Mice fasted for 6 h before the experiment were placed
individually in cages lined with clean filter paper. The
animals were divided into seven groups, each containing
six animals; the first group acted as the negative control
and was administered saline (10 ml/kg, p.o.), while the
next group received CCh (1 mg/kg, i.p.), which served
as the positive control. The next two third and fourth
groups received oral doses of Fp.Cr (30 and 100 mg/kg,
respectively). To explore the possible mechanism of the
laxative effect of the extract, three separate groups of
mice were pretreated with atropine (10 mg/kg, i.p.) 1 h
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the feces production (total number of feces and total
number of wet feces per group) in all animals was
counted, and the percentage increase in wet feces rela-
tive to that of total fecal output was considered as the
laxative effect [15].
In-vitro experiments
Gut preparations from mouse, guinea-pig and rabbit
were obtained after sacrificing the animals through
cervical dislocation; the abdomen was cut open,
required tissues were identified and isolated out
[1,14,16], and the required tissue preparations of 2-3
cm length were mounted in 10 ml tissue baths con-
taining the Tyrode’s solution, maintained at 37 °C and
aerated with a mixture of 5% carbon dioxide and 95%
oxygen (carbogen). The composition of Tyrode’ss o l u -
tion (mM) was KCl 2.68, NaCl 136.9, MgCl2 1.05,
NaHCO3 11.90, NaH2PO4 0.42, CaCl2 1.8, and glucose
5.55 (pH 7.4). A preload of 1 g was applied to each tis-
sue, and the contractile responses were recorded using
isotonic transducer 50-6360 (Harvard Apparatus, Hol-
liston, MA, USA) coupled with either a student oscillo-
graph (Harvard Apparatus) or PowerLab (ML-845)
data acquisition system (AD Instruments; Sydney, Aus-
tralia) and a computer using chart software (version
5.3). The tissues were allowed to equilibrate for a per-
iod of 30 min, and then stabilized with a sub-maximal
concentration of ACh (0.3 μM). The tissues were pre-
sumed stable only after the reproducibility of the said
responses. The plant extract was examined later for
any spasmodic activity on the ileum and jejunum pre-
parations of mouse, guinea-pig and rabbit at concen-
trations ranging from 0.01 to 5.0 mg/ml.
Statistical analysis
All the data except EC50 values are expressed as mean ±
standard error of mean (S.E.M.), while “n” represents
number of animals/experiments). The median effective
concentrations (EC50 values) are geometric means with
95% confidence intervals (CIs). One way analysis of var-
iance (ANOVA) followed by Dunnett’s test or unpaired
t-test was used to assess the laxative activity, while one-
way ANOVA followed by Tukey’s test was employed for
the effect of plant extract in charchoal meal transit. The
concentration-response curves (CRCs) to the agonist
responses were analysed by non-linear regression and
two-way ANOVA followed by Bonferroni’s post-test
correction or unpaired t-test was used for multiple com-
parisons of CRCs with the respective control. All the
graphing, calculations and statistical analysis were per-
formed using GraphPad Prism 4 for windows (GraphPad
Software, San Diego, California, USA).
Results
Phytochemical analysis
Preliminary phytochemical analysis of Fp.Cr revealed the
presence of alkaloids, saponins, anthraquinones and
tannins.
In-vivo findings
Effect of Fp.Cr on charcoal meal GI transit in mice
Fp.Cr, dose-dependently (30-100 mg/kg) propelled the
charcoal meal through the small intestine of mice (Fig-
ure 1), thus showing prokinetic effect. The distance tra-
velled by the vehicle control in saline was 58.9 ± 1.7%
(mean ± S.E.M, n = 6) of total length of small intestine,
while the positive control group receiving CCh (1 mg/
kg) significantly enhanced the movement (p < 0.001 ver-
sus saline) of charcoal meal to 96.3 ± 1.8%. The plant
extract at the doses of 30 and 100 mg/kg significantly (p
< 0.001) enhanced the movement of charcoal meal to 71
± 2.2% and 85.8 ± 2.3% respectively, when compared
with saline treated group (58.9 ± 1.7%). Pretreatment of
animals with atropine (1 mg/kg) significantly reduced
the prokinetic effect of the plant extract and CCh as
shown in Figure 1.
Laxative activity
The treatment with Fp.Cr (30 and 100 mg/kg) produced
61.2 ± 2.2% and 71 ± 3.2% (mean ± S.E.M, n = 6) wet
feces in mice. The positive control, CCh (1 mg/kg) pro-
duced 79.5 ± 3.3% wet feces, while the saline treated
g r o u pd i dn o tf o r ma n yw e tf e c e s .P r e t r e a t m e n to fa n i -
mals with Fp.Cr (30 and 100 mg/kg) reduced wet feces
to 30 ± 4.3% and 10.6 ± 5.0% respectively, while the
reduction in CCh-induced wet feces (6.0 ± 3.8%) was
more pronounced as evident in Table 1.
In-vitro findings
Effect of Fp.Cr on ileum preparation of different animals
Fp.Cr at 0.01-0.3 mg/ml caused a stimulatory effect in
isolated mouse ileum with efficacy of 62.5 ± 2.2% of
ACh maximum, as shown in Figure 2A. Pretreatment of
t h et i s s u ew i t ha t r o p i n e( 0 . 1μM) abolished the spasmo-
genic effect of Fp.Cr, while pretreatment of the tissue
with hexamethonium, pyrilamine, or SB203186 had no
effect (Figure 2A). The values determined in Figure 2A
have been acquired from 4-7 separate experiments car-
ried out on the isolated tissues of 4 animals.
In guinea-pig ileum, the plant extract caused stimula-
tory effect in a concentration-dependent (0.01-3 mg/ml)
manner with maximum effect (93.2 ± 1%) reaching close
to that of ACh maximum. Pretreatment of the tissue
with atropine (0.1 μM), but not with hexamethonium,
pyrilamine, or SB203186, partially blocked (p < 0.001)
the spasmogenic effect of Fp.Cr (Figure 2B).
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Page 3 of 8In rabbit ileum, Fp.Cr did not show any stimulatory
effect on tested concentrations of 0.003-0.3 mg/ml (Fig-
ure 2C).
Effect of Fp.Cr on jejunum preparation of different
animals
In mouse jejunum, Fp.Cr, caused a concentration-
dependent (0.01-1 mg/ml) stimulant effect with efficacy
of 62 ± 3% being less potent (p < 0.05) than in mouse
ileum. Pretreatment of the tissue with atropine (0.1 μM)
blocked the spasmogenic effect of Fp.Cr (Figure 2D).
In guinea-pig jejunum, Fp.Cr (0.1-3 mg/ml) exhibited
a spasmodic effect reaching its maximum to 70 ± 0.8%
of ACh maximum, which was less than that obtained in
ileum (p < 0.05). Like in ileum, pretreatment of tissue
with atropine partially blocked the stimulatory effect of
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Figure 1 Bar diagram showing the dose-dependent effect of the crude extract of Fumaria parviflora (Fp.Cr) on travel of charcoal meal
through small intestine of mice, in the absence and presence of atropine.* p < 0.05, **p < 0.01 and ***p < 0.001, one-way ANOVA
followed by Tukey’s test.
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Page 4 of 8Fp.Cr, while pretreatment with hexamethonium, pyrila-
mine or SB203186 had no influence on the stimulatory
effect of Fp.Cr (Figure 2E).
When tested in spontaneously contracting rabbit jeju-
num, the plant extract exhibited a concentration-depen-
dent (0.01-0.3 mg/ml) stimulatory effect. The efficacy of
the spasmogenic effect was 78.1 ± 3% of ACh maximum
observed at 0.3 mg/ml. Pretreatment of the tissue with
atropine (0.1 μM) completely blocked the spasmogenic
effect of Fp.Cr, while the presence of hexamethonium,
pyrilamine or SB203186 did not alter its effect (Figure
2F).
Discussion
When studied for its prokinetic and laxative effects in
mice, the plant extract caused propulsion of charcoal
meal through small intestine and increased the produc-
tion of wet feces, similar to the effect of CCh, a standard
cholinergic agonist and accelerator of intestinal contents
[17]. These gut stimulatory actions of the extract were
partially suppressed when studied in the presence of
atropine, a muscarinic receptor blocker [18], indicating
the presence of some other gut stimulant constituent(s),
in addition to ACh-like component(s). ACh is a neuro-
transmitter of the parasympathetic nervous system and
is known to cause gastrointestinal stimulation through
the activation of muscarinic receptors [17]; hence, the
presence of ACh-like constituents explains its medicinal
use in indigestion and constipation.
To further study the possible mode of the observed
prokinetic and laxative actions of the extract, the in-
vitro experiments were conducted. We used two differ-
ent preparations (jejunum and ileum) from three differ-
ent species (mouse, rabbit and guinea-pig), based on the
previous observations that the plant extract do exhibit
tissue and/or species-specific gut stimulatory effect
[14,19]. Though efficacy for spasmodic effect of the
plant extract varied in intestinal preparations from
mouse (jejunum and ileum) and rabbit (jejunum), but its
stimulant effect was completely blocked by atropine,
thus, showing a common mechanism of gut stimulatory
effect through cholinergic action, whereas, the insensi-
tivity of rabbit ileum to stimulatory components of the
extract might be due to its tissue selective effects or the
presence of some other constituent of opposite mechan-
ism more likely to be expressed in rabbit ileum. Similar
tissue specific behavior was also seen in other medicinal
herbs like, ginger [20], ispaghula [1] and black pepper
[21].
While atropine completely blocked the stimulatory
effect of plant extract in the isolated gut tissues of mice,
however, only partially blocked the prokinetic and laxa-
tive effects of the plant extract in the in-vivo studies,
which needs explanation. It is possible that the plant
extract causes release of some endogenous gut stimulant
mediator(s), other than cholinergic in nature.
In guinea-pig tissues, the observed stimulant effect of
the plant extract was partially blocked by atropine, indi-
cating that guinea-pig tissues behave differently from
those of mouse and rabbit in the nature of gut stimulant
effect, and clearly suggests some additional mechanism
(s), independent of histamine, nicotine or 5-Hydroxy-
tryptamine (5-HT, serotonin) receptors activation, which
was evident by its insensitivity to pyrilamine, a histami-
nic type-1 (H1) receptor blocker [22], hexamethonium, a
ganglion blocker [23] or SB203186, a serotonergic recep-
tor antagonist [24]. The other mechanisms known for
their gut stimulant property, which have not been ruled
out include, platelet activating factor [25], nitric-oxide-
donating or releasing compounds [26] and dopaminergic
antagonists [27].
Collectively, the data on jejunum and ileum prepara-
tions of mouse, rabbit and guinea-pig indicate a species
and tissue-selective gut stimulatory effect of Fp.Cr. The
observed stimulatory effect of the extract was fully atro-
pine-sensitive in rabbit jejunum and mouse prepara-
tions, while guinea-pig tissues showed partial sensitivity
to atropine. Rabbit ileum was insensitive to the
Table 1 Laxative effect of the crude extract of Fumaria parviflora (Fp.Cr) without and with atropine in mice
Group
No.
Treatment Dose (mg/
kg)
Mean defecation/
group
Mean number of wet feces/
group
Mean % of wet
feces
1 Saline (p.o., ml/kg) 10 3 ± 0.36 0 0
2 Carbachol (i.p.) 1 11.5 ± 0.5*** 9.1 ± 0.5 79.5 ± 3.3
3 Fp.Cr (p.o.) 30 8.3 ± 0.9** 5.2 ± 0.6 61.2 ± 2.2
4 100 11.1 ± 0.3*** 8.0 ± 1.0 71.0 ± 3.2
5 Carbachol (i.p.) + Atropine (i.
p.)
1 + 10 4.0 ± 0.5*** 0.3 ± 0.2 6.0 ± 3.8
6 Fp.Cr (p.o.) + Atropine (i.p.) 30 + 10 5.3 ± 0.9** 1.5 ± 0.2 30.0 ± 4.3
7 100 + 10 4.6 ± 0.6*** 0.5 ± 0.2 10.6 ± 5.0
Values shown are mean ± S.E.M, n = 6. **p < 0.01 and ***p < 0.001 show a comparison of group # 2,3 and 4 vs. group # 1 (One-way ANOVA followed by
Dunnett’s test), group # 5 vs. group # 2, group # 6 vs. group # 3 and group # 7 vs. group # 4 (unpaired t-test). The term p.o represent per oral, while i.p is for
intraperitoneal injection.
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Figure 2 The stimulatory effects of the crude extract of Fumaria parviflora (Fp.Cr) without and with atropine (0.1 μM), pyrilamine (1
μM), hexamethonium (0.3 mM) and SB203186 (1 μM) in isolated ileum and jejunum preparations of (A, D) Mouse, (B, E) Guinea-pig
and (C, F) Rabbit. The values shown are mean ± S.E.M of 4-7 experiments. *p < 0.05 and ***p < 0.001 (Two-way ANOVA, followed by bonferoni
post-test correction or unpaired t-test).
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Page 6 of 8stimulatory effect of the plant extract, while guinea-pig
tissues showed the highest efficacy, ileum being the
most sensitive with efficacy close to that of ACh. Such
types of species and/or tissue-selective effects of plant
extracts have also been reported in earlier studies
[1,14,19,20,28,29]. What is the pharmacological basis for
this species and/or tissue specific behavior of some
plant materials is not clear. Location and distribution of
different subtypes of different receptors vary in different
species and even difference exists within the tissues
from the same species [30]. Furthermore, sometimes,
compounds like atropine, which is not selective for any
muscarinic receptor subtype, exhibits selective behavior
in some species. For example, the potency of atropine is
found to be less in rabbit tissues than in other species,
which is believed to be due to the presence of atropi-
nase enzyme in rabbit resulting in rapid metabolism of
atropine, thus rendering it less active [31]. Similarly, the
relatively high efficacy of the plant extract in guinea-pig
tissues is possibly because of additional mechanism
(non-cholinergic), which may involve activation of
receptors, which are not present in other two species
studied, though other possibilities cannot be ruled out.
Based on these observations, a suggestion can be made
using different gut tissues from more than one species
to know the broader picture. It may be worth mention-
ing that gut stimulant effect of Fp.Cr was significantly (p
< 0.001) higher in rabbit jejunum and guinea-pig ileum,
when compared with that of Fumaria indica,a n o t h e r
species of Fumaria genus, which showed atropine-sensi-
tive stimulant effects with no species or tissue selective
behavior [7]. The observed variation in stimulatory
effects of Fp.Cr (collected from Saudi Arabia), and
Fumaria indica (collected from Pakistan), in guinea-pig
ileum and rabbit jejunum could be either due to differ-
ent plant-species or because of the effect of regional and
environmental factors. The chemical composition and
biological activity profile in the same plant grown in dif-
ferent regions are known to differ [32,33].
The plant has been shown to possess anthelmintic
activity [34] and co-existence of laxative effect might be
of added value in the expulsion of helminths, as the hel-
minthes are known to promote developing gut disorders
such as, abdominal pain, diarrhea, and constipation [35].
The presence of alkaloids, saponins [36] and anthra-
quinones [3] as the plant constituents, which are known
to possess gut stimulatory properties, may explain the
gut stimulant actions of the plant extract, though further
studies are required to know the specific chemical(s)
responsible for the tested biological activities.
Conclusion
This study showed that Fumaria parviflora possesses
prokinetic and laxative activities of in mice, which were
partially mediated through a cholinergic pathway. In the
in-vitro studies, the observed spasmodic effect of the
plant extract involved at least two pathways (atropine-
sensitive and insensitive) with species and tissue-selec-
tivity, guinea-pig tissues being the most sensitive. This
study provides sound pharmacological basis to the med-
icinal use of the plant in gut motility disorders, like indi-
gestion and constipation, and suggests using more than
one species to draw a meaningful conclusion, as no sin-
gle species can truly represent human picture.
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